James R. Gavin

3.7k total citations · 1 hit paper
75 papers, 2.3k citations indexed

About

James R. Gavin is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, James R. Gavin has authored 75 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Endocrinology, Diabetes and Metabolism, 20 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in James R. Gavin's work include Diabetes Management and Research (31 papers), Diabetes Treatment and Management (28 papers) and Pancreatic function and diabetes (16 papers). James R. Gavin is often cited by papers focused on Diabetes Management and Research (31 papers), Diabetes Treatment and Management (28 papers) and Pancreatic function and diabetes (16 papers). James R. Gavin collaborates with scholars based in United States, United Kingdom and Australia. James R. Gavin's co-authors include Joseph Levy, Richard M. Bergenstal, William H. Daughaday, Davida Kruger, Ronald L. Gingerich, Susan Grandy, Kathleen M. Fox, Elena Fuentes‐Afflick, David S. Wilkes and Nirav R. Bhakta and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

James R. Gavin

74 papers receiving 2.2k citations

Hit Papers

Race and Genetic Ancestry in Medicine — A Time for Reckon... 2021 2026 2022 2024 2021 100 200 300

Peers

James R. Gavin
Mark R. Burge United States
Wing Yee So Hong Kong
Charles M. Clark United States
Srikanth Bellary United Kingdom
Tamara S. Hannon United States
Soon Jib Yoo South Korea
Mark R. Burge United States
James R. Gavin
Citations per year, relative to James R. Gavin James R. Gavin (= 1×) peers Mark R. Burge

Countries citing papers authored by James R. Gavin

Since Specialization
Citations

This map shows the geographic impact of James R. Gavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James R. Gavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James R. Gavin more than expected).

Fields of papers citing papers by James R. Gavin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James R. Gavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James R. Gavin. The network helps show where James R. Gavin may publish in the future.

Co-authorship network of co-authors of James R. Gavin

This figure shows the co-authorship network connecting the top 25 collaborators of James R. Gavin. A scholar is included among the top collaborators of James R. Gavin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James R. Gavin. James R. Gavin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McGill, Janet B., Irl B. Hirsch, Christopher G. Parkin, et al.. (2024). The Current and Future Role of Insulin Therapy in the Management of Type 2 Diabetes: A Narrative Review. Diabetes Therapy. 15(5). 1085–1098. 6 indexed citations
2.
Gavin, James R., et al.. (2023). Therapeutic Inertia and Delays in Insulin Intensification in Type 2 Diabetes: A Literature Review. Diabetes Spectrum. 36(4). 379–384. 14 indexed citations
3.
Borrell, Luisa N., Jennifer R. Elhawary, Elena Fuentes‐Afflick, et al.. (2021). Race and Genetic Ancestry in Medicine—A Time for Reckoning With Racism. Obstetrical & Gynecological Survey. 76(7). 395–397. 19 indexed citations
4.
Ceriello, Antonio, James R. Gavin, Andrew J.M. Boulton, et al.. (2018). The Berlin Declaration: A call to action to improve early actions related to type 2 diabetes. How can specialist care help?. Diabetes Research and Clinical Practice. 139. 392–399. 10 indexed citations
5.
Schwartz, Stanley S., Solomon Epstein, Barbara E. Corkey, et al.. (2017). A Unified Pathophysiological Construct of Diabetes and its Complications. Trends in Endocrinology and Metabolism. 28(9). 645–655. 81 indexed citations
6.
Gavin, James R., Melanie J. Davies, Michael J. Davies, et al.. (2015). The efficacy and safety of canagliflozin across racial groups in patients with type 2 diabetes mellitus. Current Medical Research and Opinion. 31(9). 1693–1702. 16 indexed citations
7.
Gavin, James R., Kathleen M. Fox, & Susan Grandy. (2011). Race/Ethnicity and gender differences in health intentions and behaviors regarding exercise and diet for adults with type 2 diabetes: A cross-sectional analysis. BMC Public Health. 11(1). 533–533. 33 indexed citations
8.
Gavin, James R. & Nancy J.V. Bohannon. (2010). A Review of the Response to Oral Antidiabetes Agents in Patients with Type 2 Diabetes. Postgraduate Medicine. 122(3). 43–51. 5 indexed citations
9.
Gavin, James R.. (2007). The Importance of Monitoring Blood Glucose. US Endocrinology. 0(2). 42–42. 6 indexed citations
11.
Palmer, Andrew, Seán F. Dinneen, James R. Gavin, et al.. (2006). Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes. Current Medical Research and Opinion. 22(5). 861–872. 37 indexed citations
12.
Gavin, James R.. (2006). How Can We Implement Current Therapies and Interventions to Achieve Glycemic Control?. Endocrine Practice. 12. 93–97. 3 indexed citations
13.
Gavin, James R.. (2004). Slowing Cardiovascular Disease Progression in African‐American Patients: Diabetes Management. Journal of Clinical Hypertension. 6(s4). 26–33. 3 indexed citations
14.
Gavin, James R.. (2001). Pathophysiologic mechanisms of postprandial hyperglycemia. The American Journal of Cardiology. 88(6). 4–8. 37 indexed citations
15.
Levy, Joseph, et al.. (1994). Diabetes mellitus: A disease of abnormal cellular calcium metabolism?. The American Journal of Medicine. 96(3). 260–273. 202 indexed citations
16.
Gavin, James R.. (1990). Glyburide: New insights into its effects on the beta cell and beyond—introduction. The American Journal of Medicine. 89(2). S1–S2. 2 indexed citations
17.
Levy, Joseph, Yasuo Suzuki, Louis V. Avioli, George Grunberger, & James R. Gavin. (1988). Plasma membrane phospholipid content in non-insulin-dependent streptozotocin-diabetic rats — effect of insulin. Diabetologia. 31(5). 315–321. 12 indexed citations
18.
Phillips, Lawrence S., S. Goldstein, & James R. Gavin. (1988). Nutrition and somatomedin XVI: Somatomedins and somatomedin inhibitors in fasted and refed rats. Metabolism. 37(3). 209–216. 16 indexed citations
19.
Frazer, Teresa, James R. Gavin, William H. Daughaday, Richard E. Hillman, & Virginia V. Weldon. (1982). Growth hormone-dependent growth failure. The Journal of Pediatrics. 101(1). 12–15. 80 indexed citations
20.
Gorden, P, James R. Gavin, C R Kahn, et al.. (1973). Application of Radioreceptor Assay to Circulating Insulin, Growth Hormone, and to Their Tissue Receptors in Animals and Man. Pharmacological Reviews. 25(2). 179–187. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026